Cathie Wood is defending CoreWeave's debt after ARK bought its stock this week
ARK bought an estimated $25.8 million of CoreWeave stock on Wednesday and Thursday while the company's bond yields neared 15%
On Thursday, October 15th, 2026, Cathie Wood’s ARK ETF made several significant transactions across various sectors. The most notable move was the purchase of 1,184,955 shares of Iambic Therapeutics (NASDAQ:IAM) for $18,959,280, indicating a strong interest in the biotechnology sector. ARK also increased its stake in Recursion Pharmaceuticals (NASDAQ:RXRX) by acquiring 4,230,235 shares for $15,821,078, continuing its focus on innovative biotech firms.
In the tech sector, ARK bought 192,566 shares of CoreWeave (NASDAQ:CRWV) for $12,666,991, while also accumulating shares of Rocket Lab Corp (NASDAQ:RKLB) and selling shares of Amazon.com Inc. (NASDAQ:AMZN), Shopify Inc. (NYSE:SHOP), and Palantir Technologies Inc. (NYSE:PLTR). Overall, the ETF’s activity highlights a strategic reallocation towards biotechnology and innovative tech companies, while reducing exposure to select large-cap tech stocks.
Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
